3.1 Compare hard gelatin capsules with soft gelatin capsules.

Hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs) differ significantly in
composition, manufacturing, and applications:

Structure and Composition: • HGCs: Two-piece shells (cap and body) that fit together;
gelatin content 12-16%, moisture 13-16% • SGCs: One-piece seamless construction;
higher gelatin content, plasticizers (glycerin, sorbitol) at 20-30%, lower final moisture
content (6-10%)

Manufacturing: • HGCs: Produced by dipping metal pins into gelatin solution, drying,
removing, trimming, and joining • SGCs: Produced by rotary die process where two
gelatin ribbons are brought together around liquid fill in one continuous operation

Fill Materials: • HGCs: Primarily powders, granules, pellets, and occasionally non-
aqueous liquids • SGCs: Liquids, solutions, suspensions, semi-solids, oils, and self-
emulsifying systems

Sealing: • HGCs: Mechanical interlocking of body and cap, with optional banding or
sealing • SGCs: Hermetically sealed during manufacturing process

Advantages/Limitations: • HGCs: Easier in-house filling, lower cost, accommodate

various fill forms, sensitive to moisture • SGCs: Better content uniformity for liquids,
enhanced bioavailability for poorly soluble drugs, superior protection from oxygen,
higher production cost

Applications: • HGCs: Wide range of formulations, doses, and release profiles • SGCs:
Poorly soluble drugs, oxidation-sensitive compounds, accurate liquid dosing, lipophilic
drugs

Both forms offer taste/odor masking, elegant appearance, and ease of swallowing, but
are selected based on formulation requirements, drug properties, and target product
profile.
3.2 Explain the quality control test for capsule.

Quality control tests for capsules ensure consistent product quality and performance:

1. Weight Variation: For hard gelatin capsules, 20 units are individually weighed,
contents removed, shells reweighed, and net content calculated. Acceptance
criteria: for fill weight ≥300mg, ±7.5% deviation allowed; for <300mg, ±10%
allowed. For soft gelatin capsules, intact capsules are weighed with similar
limits.

2. Content Uniformity: Ten individual capsules are assayed for active ingredient
content. Acceptance value (AV) ≤15.0 with no individual unit outside 75-125% of
labeled content. Required for low-dose drugs or when API is <50mg or <50% of
fill weight.

3. Disintegration: Capsules must disintegrate within 30 minutes for HGCs and 60

minutes for SGCs in specified media at 37±2°C using pharmacopoeial
apparatus.

4. Dissolution: Measures drug release rate in dissolution medium using USP

apparatus (typically basket method). Product-specific specifications define Q-
value and time point.

5. Moisture Content: Particularly critical for HGCs; measured by loss on drying or

Karl Fischer titration. Typical specification: 13-16% for HGC shells, 6-10% for
SGCs.

6. Shell Integrity: • Lock length verification for HGCs • Seal integrity testing for
SGCs • Visual inspection for defects

7. Specific Tests for SGCs: • Rupture test: Capsule must rupture within specified
time • Leakage test: Absence of liquid leakage under pressure

8. Microbial Limits: Total aerobic microbial count, total yeast/mold count, absence
of specified pathogens.

These tests ensure product quality, stability, batch uniformity, and therapeutic
performance throughout shelf life.
3.3 Write a brief note on the size of capsules.

Capsule sizes are standardized and numbered according to their volumetric capacity,
with larger numbers indicating smaller capsules. The standard range for hard gelatin
capsules includes:

• Size 000: Largest standard size, capacity ~1.37mL, typically holds 950-1100mg of
powder depending on density • Size 00: Capacity ~0.95mL, typically holds 650-800mg
powder • Size 0: Capacity ~0.68mL, typically holds 450-550mg powder • Size 1:
Capacity ~0.50mL, typically holds 350-400mg powder • Size 2: Capacity ~0.37mL,
typically holds 250-300mg powder • Size 3: Capacity ~0.30mL, typically holds 200-
225mg powder • Size 4: Capacity ~0.21mL, typically holds 150-170mg powder • Size 5:
Smallest standard size, capacity ~0.13mL, typically holds 65-100mg powder

Special sizes include: • Size 000E: Elongated version of 000, offering greater capacity
(~1.5mL) • Veterinary sizes (designated with "el"): Specially sized for animal dosing

Actual fill weight depends on powder bulk density, with the formula: Fill weight =
Volume capacity × Tapped density × Fill factor (typically 0.65-0.75)

Size selection considerations include: • Drug dose requirements • Powder bulk density
• Flow characteristics of formulation • Patient swallowability (larger sizes may be
difficult for some patients) • Target patient population (pediatric vs. adult) •
Manufacturing equipment capabilities

The appropriate capsule size balances adequate capacity for the formulation with
patient acceptability and manufacturing efficiency.
3.4 Explain size of capsules and write a note on problem and remedies in capsules.

Hard gelatin capsules are available in standard sizes numbered from 000 (largest) to 5
(smallest): • Size 000: ~1.37mL capacity, holds 950-1100mg powder • Size 00: ~0.95mL
capacity, holds 650-800mg powder • Size 0: ~0.68mL capacity, holds 450-550mg
powder • Size 1: ~0.50mL capacity, holds 350-400mg powder • Size 2: ~0.37mL
capacity, holds 250-300mg powder • Size 3: ~0.30mL capacity, holds 200-225mg
powder • Size 4: ~0.21mL capacity, holds 150-170mg powder • Size 5: ~0.13mL
capacity, holds 65-100mg powder

Special sizes include 000E (elongated) and veterinary sizes (AAel, Bel).

Size selection depends on drug dose, powder density, and patient acceptability, with fill
weight calculated as: Volume capacity × Tapped density × Fill factor (0.65-0.75).

Common capsule problems and remedies:

1. Brittleness: • Problem: Shells crack or break during filling • Causes: Excessive

drying, low humidity storage • Remedies: Store at 40-45% RH, condition shells
before filling

2. Softness/Deformation: • Problem: Shells too soft for machinery handling •

Causes: High humidity exposure • Remedies: Control environmental conditions,
temporary storage with desiccants

3. Weight Variation: • Problem: Inconsistent fill weights • Causes: Poor powder

flow, improper machine settings • Remedies: Improve flow with glidants,
optimize machine parameters, ensure uniform blend density

4. Capsule Locking Issues: • Problem: Failure to close properly • Causes:

Overfilling, powder on shell rims • Remedies: Adjust fill weight, implement
cleaning mechanisms

5. Cross-contamination: • Problem: Residue from previous products • Causes:

Inadequate cleaning • Remedies: Thorough equipment cleaning, dedicated
equipment for potent compounds

6. Dissolution Failures: • Problem: Slow or inconsistent drug release • Causes:

Poor wetting, excessive compaction • Remedies: Add disintegrants, reduce
powder compaction force

7. Splitting during storage: • Problem: Capsules split along seams • Causes:

Hygroscopic fill material, moisture migration • Remedies: Use moisture-
protective packaging, consider desiccants
 8. Appearance defects: • Problem: Spots, discoloration, dimples • Causes:
Manufacturing issues, moisture effects • Remedies: Quality control of shells,
proper storage conditions

3.5 Explain the method in detail to prepare hard gelatin capsule shell.

The manufacturing process for hard gelatin capsule shells involves several carefully
controlled steps:

1. Gelatin Solution Preparation: • Type A (acid-processed) and/or Type B (alkali-

processed) gelatin is weighed • Gelatin is added to purified water at controlled
temperature (60-80°C) • Gentle agitation is maintained until complete
dissolution • Colorants, opacifiers (titanium dioxide), and preservatives are
added if required • Solution is precisely adjusted to 28-32% solids content •
Viscosity is controlled (typically 1000-1500 centipoises at 45°C) • Solution is
deaerated under vacuum to remove air bubbles

2. Dipping Process: • Sets of stainless steel pins (molds) mounted on bars are
preheated • Pins are lubricated with a release agent • Dipping bars lower pins
into temperature-controlled gelatin solution • Precise dipping depth and dwell
time control shell length and thickness • Cap and body pins have different
lengths and diameters for proper fit • Gelatin solution adheres to pins as a
uniform film

3. Rotation and Drying: • Pins with gelatin coating are withdrawn and begin rotating
• Rotation ensures even gelatin distribution and uniform wall thickness • Initial
drying occurs in controlled airflow • Pins move through progressive drying
chambers • Temperature and humidity are precisely controlled (20-25°C, 35-45%
RH) • Drying time typically 1.5-3 hours depending on size

4. Stripping and Trimming: • Dried shells are mechanically removed from pins •
Automatic cutting systems trim shells to precise lengths • Cap lengths are
typically 40-50% of total capsule length • Body lengths are 60-70% of total
capsule length

5. Joining and Finishing: • Caps and bodies are automatically aligned • Bodies are
inserted partially into caps to create pre-locked position • Shells undergo final
drying to achieve optimal moisture content (13-16%) • Finished capsules are
visually inspected for defects

6. Quality Control: • Dimensional checks (length, diameter, wall thickness) •

Moisture content verification • Visual inspection for defects • Weight variation
testing • Joint integrity evaluation
Modern automatic machines can produce 40,000-150,000 capsules per hour with
precise control over all process parameters to ensure consistent quality.
3.6 Enumerate the size of capsules. Explain the formulation process of hard gelatin
capsules.

Hard gelatin capsule sizes in descending order of capacity: • Size 000: ~1.37mL
capacity (largest standard size) • Size 00: ~0.95mL capacity • Size 0: ~0.68mL capacity •
Size 1: ~0.50mL capacity • Size 2: ~0.37mL capacity • Size 3: ~0.30mL capacity • Size 4:
~0.21mL capacity • Size 5: ~0.13mL capacity (smallest standard size)

Special sizes include elongated versions (000E) and veterinary sizes (AAel, Bel).

Formulation process for hard gelatin capsules:

1. Preformulation Studies: • API characterization (particle size, flow, density,

compatibility) • Capsule size selection based on dose and powder density • Fill
weight calculation: Volume capacity × Tapped density × Fill factor (0.65-0.75) •
Selection of appropriate excipients based on formulation goals

2. Formulation Development: • Diluent selection: For low-dose drugs (lactose,

MCC, starch) • Flow enhancers: Addition of glidants (colloidal silica, talc) if
needed • Disintegrants: Incorporation of agents to promote capsule content
dispersion • Lubricants: Limited amounts (0.5-1%) to prevent sticking during
filling • Blending: Proper mixing sequence and technique to ensure content
uniformity

3. Manufacturing Process:

a) Powder Preparation: • API particle size reduction if required • Blending of API with
excipients • Sequential addition of glidants and lubricants • Uniformity testing of final
blend

b) Capsule Filling Methods: • Manual filling: For small-scale or clinical batches • Semi-
automatic filling: Using bench-top equipment with filling trays • Automatic filling using
Dosator-principle machines (Zanasi, MG2):

o Empty capsules loaded into rectification system

o Separation of caps and bodies

o Dosator compresses powder in powder bed

o Transfer of formed plug to capsule body

o Rejoining of cap and body

o Ejection of filled capsule

c) Alternative filling approaches: • Tamping-pin machines (Höfliger-Karg): Multiple

compression steps • Vacuum-assisted filling for cohesive powders • Specialized
systems for pellets or semi-solids
4. Finishing Operations: • Removal of external powder by vacuum or air jet •
Polishing to improve appearance • Visual inspection for defects • Weight checks
and content uniformity testing
3.7 Write a note on excipients used in the formulation of hard gelatin capsules.

Excipients used in hard gelatin capsule formulations serve specific functions to ensure
optimal product performance:

1. Diluents/Fillers: • Purpose: Increase bulk for low-dose drugs, improve flow and
uniformity • Examples: Lactose (anhydrous, monohydrate), microcrystalline
cellulose, calcium phosphate dibasic, mannitol, starch • Considerations:
Particle size, flow properties, compatibility with API, hygroscopicity

2. Glidants/Flow Enhancers: • Purpose: Improve flow properties of powder blend

for uniform filling • Examples: Colloidal silicon dioxide (Aerosil, 0.1-0.5%), talc
(1-5%), magnesium silicate • Considerations: Effective at low concentrations,
distribute on particle surfaces

3. Lubricants: • Purpose: Reduce adhesion to metal surfaces during filling, improve

flow • Examples: Magnesium stearate (0.25-1%), sodium stearyl fumarate,
stearic acid • Considerations: Used sparingly to avoid hydrophobicity issues
affecting dissolution

4. Disintegrants: • Purpose: Promote rapid dispersion of capsule contents in GI

fluids • Examples: Croscarmellose sodium (2-5%), sodium starch glycolate (2-
8%), crospovidone (2-5%) • Considerations: May be more critical for poorly
soluble drugs

5. Wetting Agents: • Purpose: Enhance wettability of hydrophobic drugs •

Examples: Sodium lauryl sulfate (0.1-0.5%), polysorbates (0.1-1%) •
Considerations: Particularly important for poorly water-soluble compounds

6. Adsorbents: • Purpose: Adsorb liquids/semi-solids to produce dry, flowable

powders • Examples: Colloidal silicon dioxide, kaolin, magnesium aluminum
silicate • Considerations: High surface area materials with liquid adsorption
capacity

7. Solubilizers: • Purpose: Enhance dissolution of poorly soluble drugs • Examples:

Polyethylene glycols, cyclodextrins, surfactants • Considerations: May improve
bioavailability of BCS Class II/IV drugs

8. Antioxidants/Stabilizers: • Purpose: Protect oxidation-sensitive drugs •

Examples: Ascorbic acid, BHT, sodium metabisulfite • Considerations: Selected
based on specific degradation pathways

The selection and proportion of these excipients is based on the physicochemical

properties of the active ingredient, desired release profile, manufacturing process, and
stability requirements. Compared to tablets, capsule formulations typically require
fewer excipients and lower processing forces, making them suitable for sensitive or low-
dose drugs.
3.8 Write a note on excipients and additives used in the capsule formulation.

Excipients and additives in capsule formulations fulfill specific functions to ensure

optimal product quality, stability, and performance:

For Hard Gelatin Capsule Fill:

1. Diluents/Fillers: • Function: Provide bulk, improve flow, ensure uniform filling •

Examples: Lactose, microcrystalline cellulose (Avicel), starch, mannitol, dibasic
calcium phosphate • Considerations: Physical compatibility, flow properties,
hygroscopicity

2. Glidants: • Function: Reduce interparticle friction, improve flow • Examples:

Colloidal silicon dioxide (Aerosil, 0.1-0.5%), talc (1-3%) • Considerations:
Surface area, distribution among particles

3. Lubricants: • Function: Reduce adhesion to metal surfaces during filling •

Examples: Magnesium stearate (0.25-1%), sodium stearyl fumarate, stearic acid
• Considerations: Used sparingly to avoid hydrophobicity issues

4. Disintegrants: • Function: Promote capsule content dispersion after

administration • Examples: Croscarmellose sodium, sodium starch glycolate,
crospovidone (2-5%) • Considerations: May be placed within or outside granules
in granulated formulations

5. Wetting Agents: • Function: Enhance hydration of hydrophobic substances •

Examples: Sodium lauryl sulfate (0.1-0.5%), polysorbates • Considerations:
Critical for poorly water-soluble drugs

For Soft Gelatin Capsule Fill:

1. Solvents/Vehicles: • Function: Dissolve or suspend active ingredients •

Examples: Vegetable oils, PEG 400, medium-chain triglycerides, glycerin •
Considerations: Solubilizing capacity, compatibility with shell

2. Solubilizers: • Function: Enhance drug solubility in vehicles • Examples:

Surfactants, co-solvents, self-emulsifying systems • Considerations:
Concentration limited by potential shell interactions

3. Suspending Agents: • Function: Maintain uniform dispersion of insoluble drugs •

Examples: Beeswax, hydrogenated vegetable oils, colloidal silicon dioxide •
Considerations: Maintain suitable viscosity for filling operation

For Capsule Shell Components:

1. Plasticizers (for SGCs): • Function: Increase flexibility, reduce brittleness •

Examples: Glycerin (20-30%), sorbitol, propylene glycol • Considerations:
Impact on shell mechanical properties and stability
 2. Colorants: • Function: Product identification, brand identity, UV protection •
Examples: FD&C and D&C dyes, iron oxides, titanium dioxide (opacifier) •
Considerations: Regulatory status, stability

3. Preservatives: • Function: Prevent microbial growth • Examples: Parabens,

potassium sorbate, ethanol • Considerations: More critical for soft gelatin
formulations

Selection of these excipients is guided by API properties, desired release profile,

manufacturing process, and stability requirements while minimizing potential
interactions.
3.9 Describe the Uniformity of weight and Uniformity of content for capsules as per
the Indian Pharmacopoeia.

According to Indian Pharmacopoeia (IP), the quality of capsules is evaluated through

two critical tests:

Uniformity of Weight:

1. For hard gelatin capsules: • Weigh 20 intact capsules individually and determine
average weight • Remove contents of each capsule, clean and reweigh empty
shells • Calculate net content weight for each capsule by subtraction • Calculate
average net content weight • For average net content ≥300mg: Not more than 2
capsules should deviate by >7.5% from average • For average net content
<300mg: Not more than 2 capsules should deviate by >10% from average • No
capsule should deviate by more than twice these percentages

2. For soft gelatin capsules: • Weigh 20 intact capsules individually and determine
average weight • Same deviation limits apply as for hard capsules • Alternative
method: Cut open capsules, remove and wash contents, dry shells, and weigh

Uniformity of Content: Required for capsules containing less than 50mg or less than
50% of active ingredient.

1. Procedure: • Assay 10 individual capsules for active ingredient content using

validated analytical method • Calculate individual content as percentage of
labeled amount • Calculate acceptance value (AV) using formula: AV = |M - ̄X| +
ks Where: M = reference value (generally 100% of label claim) X ̄ = mean of
individual contents k = acceptability constant (2.4 for n=10) s = sample standard
deviation

2. Acceptance criteria: • AV ≤ 15.0 • No individual content is outside 75-125% of

the labeled content • If not met, test additional 20 units with modified AV
calculation • Special acceptance criteria apply for certain dosage forms

These tests ensure batch uniformity and accuracy of dosing, which are critical for
therapeutic effectiveness and safety. The IP requirements align with international
standards including USP and EP, ensuring globally harmonized quality standards.
3.10 Describe the Rotary die process for manufacturing of soft gelatin capsules.

The rotary die process is the primary method for industrial-scale manufacture of soft
gelatin capsules (SGCs). This continuous process simultaneously forms, fills, and seals
capsules in one operation.

Key components of the system include:

1. Gelatin Preparation: • Gelatin (150-250 Bloom strength) is dissolved in purified

water (35-45%) • Plasticizers (glycerin, sorbitol, propylene glycol) added at 20-
30% • Colorants, opacifiers, and preservatives incorporated as needed •
Solution heated to 60-65°C with mixing • Deaeration under vacuum to eliminate
air bubbles • Final viscosity adjustment to optimal processing parameters

2. Fill Material Preparation: • Active ingredient(s) formulated in suitable vehicles

(oils, PEGs, MCTs) • Homogenization and deaeration to ensure uniformity •
Temperature adjustment to optimize flow properties during filling

3. Rotary Die Process Operation: • Two gelatin ribbon sheets formed by passing
warm gelatin solution over temperature-controlled drums or spreader boxes •
Gelatin ribbons guided to converge at the rotary die assembly • Fill material
simultaneously injected between gelatin ribbons at the convergence point •
Rotary die mechanism consists of two counter-rotating dies with matching
pockets • Dies cut, seal, and shape the capsules in one continuous motion • Die
temperature controlled (typically 35-45°C) to ensure proper sealing without
degradation • Fill volume precisely metered by positive displacement pump • Die
rolls create hermetic seal around fill material through pressure and heat

4. Post-Formation Processing: • Newly formed capsules transported through

washing system to remove lubricants • Initial drying in tumbling drums with
controlled air flow • Capsules carefully transferred to drying tunnels/trays •
Controlled drying conditions (20-30% RH, 21-24°C) for 24-72 hours • Gradual
moisture reduction to final 6-10% content • Inspection for defects using
automated vision systems • Sorting to remove malformed or leaking capsules

This process can produce up to 120,000 capsules per hour with precise content
uniformity, hermetic sealing, and consistent quality. Modern rotary die processes
include computer control systems to monitor and adjust critical parameters throughout
production.
3.11 Write a note on rotary die process.

The rotary die process is the predominant industrial method for manufacturing soft
gelatin capsules, offering high efficiency and precision in a continuous operation.

Process Principles: The system simultaneously forms, fills, and seals capsules by
bringing together two gelatin ribbons around a metered dose of fill material, followed by
die-cutting and sealing operations in one continuous motion.

Key Components:

1. Gelatin Feed System: • Temperature-controlled gelatin solution (35-45% gelatin

with plasticizers) • Spreader boxes that cast gelatin onto rotating stainless steel
drums • Thickness control systems to ensure uniform ribbon formation (0.5-
1.5mm) • Gelatin ribbon lubrication systems to prevent sticking

2. Fill Delivery System: • Temperature-controlled fill material reservoir • Positive

displacement pumps for precise volumetric dosing • Injection wedge positioned
at convergence point of gelatin ribbons • Heated fill lines to maintain optimal
viscosity

3. Rotary Die Assembly: • Two counter-rotating metal dies with matching cavities •
Precision-engineered die pockets defining capsule shape and size • Temperature
control systems maintaining optimal sealing conditions • Pressure adjustment
mechanisms for proper seal formation

4. Capsule Formation Mechanism: • Gelatin ribbons meet at die interface with fill
material injected between them • Dies cut through both gelatin sheets while
simultaneously sealing edges • Pressure and temperature create hermetic seal
around fill material • Formed capsules are ejected from die assembly

5. Post-Formation Processing: • Washing system to remove lubricants and debris •

Drying tunnels with controlled temperature/humidity • Inspection and sorting
systems

Process Advantages: • High production capacity (40,000-120,000 capsules/hour) •

Excellent hermetic sealing properties • Precise fill volume control (±3% typical) •
Flexibility in capsule shape and size • Continuous operation capability

Critical Process Parameters: • Gelatin ribbon thickness and temperature • Die

temperature and pressure • Fill material temperature and viscosity • Rotational speed
of dies • Seal width and integrity

Modern rotary die processes incorporate computerized control systems, automated

inspection, and real-time process monitoring to ensure consistent quality and
efficiency.
3.12 Discuss formulation of soft gelatin capsule shell.

Soft gelatin capsule (SGC) shell formulation requires careful consideration of materials
and proportions to ensure optimal mechanical properties, stability, and manufacturing
performance:

Primary Components:

1. Gelatin (40-60% of dry shell weight): • Type A (acid-processed) or Type B (alkali-

processed), often in combination • Bloom strength typically 150-250g (higher
than HGCs) • Higher bloom strength provides firmer gel, better mechanical
properties • Contributes to shell elasticity, strength, and oxygen barrier
properties • Quality attributes: clarity, color consistency, microbial
specifications

2. Plasticizers (20-30% of dry shell weight): • Essential for flexibility and elasticity •
Primary options:

o Glycerin: Most common, good plasticizing efficiency

o Sorbitol: Alternative with lower hygroscopicity

o Propylene glycol: Enhances shell clarity, lower moisture absorption

o Combinations often used for optimal properties • Ratio to gelatin is

critical for shell mechanical properties

3. Water (30-40% during formation, 6-10% in final product): • Initial high content for
processing • Controlled removal during drying • Final moisture content critical
for stability

Additional Components:

4. Opacifiers/Colorants (0-5%): • Titanium dioxide: Primary opacifier • Iron oxides:

Brown, red, yellow pigments • FD&C and D&C dyes: Various colors • Distribution
must be uniform in gelatin mass

5. Preservatives (0.1-0.2%): • Prevent microbial growth • Options include:

o Methyl/propyl parabens

o Potassium sorbate

o Sorbic acid

6. Specialized additives: • Flavoring agents (for chewable formulations) •

Sweeteners (for chewable formulations) • pH modifiers (buffering agents) • EDTA
as antioxidant synergist

Formulation Considerations:
• Shell thickness control: Typically 0.5-1.5mm based on application • Oxygen barrier
requirements: Influenced by gelatin grade and thickness • Compatibility with fill
material: Testing required to ensure no adverse interactions • Mechanical properties:
Elasticity, puncture resistance, seal integrity • Dissolution characteristics: Time to
rupture and release contents • Stability considerations: Moisture exchange with fill,
brittleness development

The precise formulation is adjusted based on specific product requirements, fill

material properties, manufacturing equipment specifications, and stability
considerations.
3.13 Explain the stability aspect of soft gelatin capsule and give its application.

Stability Aspects of Soft Gelatin Capsules:

1. Physical Stability Challenges: • Shell Softening: Occurs when fill components

migrate into shell, causing plasticization

o Control: Selection of compatible fill materials, barrier coatings • Shell

Hardening/Brittleness: Results from plasticizer loss, dehydration, or
cross-linking

o Control: Proper storage conditions (20-25°C, 40-60% RH), antioxidants •

Pellicle Formation: Thin, tough film on surface due to drying

o Control: Appropriate packaging, humidity control

2. Chemical Stability Considerations: • Cross-linking: Reaction between gelatin

and aldehydes leading to reduced solubility

o Control: Avoid aldehyde-generating excipients, add amine compounds as

aldehyde scavengers • Fill-Shell Interactions: Migration of fill components
causing destabilization

o Control: Compatibility testing, pH adjustment of fill • Oxidative

Degradation: Particularly for unsaturated oils or oxidation-sensitive drugs

o Control: Antioxidants, nitrogen flushing, impermeable packaging

3. Stability Factors: • Moisture Content: Critical parameter (6-10% optimal) •

Temperature: Accelerates deterioration above 25°C • Oxygen Exposure: Leads to
oxidation and cross-linking • Light: Can catalyze oxidation reactions • pH of Fill:
Extremes can affect shell integrity

Applications of Soft Gelatin Capsules:

1. Pharmaceutical Applications: • Poorly Water-Soluble Drugs (BCS Class II/IV):

o Enhanced solubility and bioavailability

o Examples: Cyclosporine, tacrolimus, vitamin D analogs • Liquid/Semi-

solid Formulations:

o Accurate dosing of liquids

o Examples: Vitamin E, omega-3 fatty acids • Oxidation-Sensitive

Compounds:

o Protection from oxygen due to hermetic sealing

o Examples: CoQ10, fish oils, vitamin A • Taste/Odor Masking:

 o Complete encapsulation of unpleasant substances

o Examples: Fish oils, garlic extracts, valproic acid

2. Special Delivery Systems: • Self-Emulsifying Drug Delivery Systems (SEDDS):

o Enhance dissolution of lipophilic drugs

o Example: Norvir (ritonavir) • Sustained-Release Formulations:

o Using specialized fill formulations

o Example: Verapamil SR capsules

3. Consumer Health/Nutraceutical Applications: • Dietary Supplements:

o Vitamins A, D, E, K

o Omega-3 fatty acids

o Herbal extracts • Cosmetic Applications:

o "Beauty from within" supplements

o Examples: Evening primrose oil, collagen supplements

SGCs combine stability advantages of hermetic sealing with enhanced bioavailability

for appropriate compounds, making them valuable for specific formulation challenges.
3.14 Define Base absorption capacity and bloom strength with respect to soft
gelatin capsule. Explain its importance and methods used to measure it.

Base Absorption Capacity:

Definition: Base absorption capacity (BAC) refers to the tendency of soft gelatin capsule
shells to absorb components from the fill material, particularly oils, solvents, and
plasticizers. It represents the maximum amount of fill material that can be absorbed by
the shell without compromising integrity.

Importance: • Determines capsule shelf life and stability • Affects drug migration
between fill and shell • Influences shell physical properties during storage • Impacts
dissolution characteristics over time • Guides selection of appropriate fill formulations

Measurement Methods:

1. Weight Change Method: • Empty shell pieces are accurately weighed • Shell
samples are immersed in specific fill component • Samples are removed at
predetermined intervals • Excess solvent is carefully removed • Samples are
reweighed to determine absorption percentage • Absorption typically expressed
as mg absorbed per gram of shell

2. Disk Method: • Standardized gelatin disks are prepared with composition

matching shell • Disks are placed in contact with fill material • Weight gain and
dimensional changes are monitored over time • Rate and extent of absorption

Bloom Strength:

Definition: Bloom strength is a measure of gelatin's gel strength or firmness, determined

by the force (in grams) required to depress a standard plunger 4mm into a 6.67% w/w
gelatin gel that has been prepared and conditioned under standardized conditions.

Importance: • Primary indicator of gelatin quality and functional properties •

Determines mechanical properties of the capsule shell • Influences shell elasticity and
resistance to rupture • Affects manufacturing processability (ribbon formation, die
cutting) • Impacts drying characteristics and final shell properties • Higher bloom
strength generally provides better oxygen barrier properties

Measurement Methods:

1. Standard Bloom Test (GMIA/AOAC Method): • Prepare 6.67% w/w gelatin solution
in standard bloom jars • Mature gel at 10°C for 16-18 hours • Measure force
required to depress standard plunger 4mm into gel surface • Bloom values
typically range from 50-300g (SGCs typically use 150-250g)

2. Texture Analyzer Method: • Modern instrumentation using similar principles •

Automated measurement with digital force recording • Allows more precise
 control of test parameters • Can provide additional textural parameters beyond
simple bloom value

SGC manufacturers carefully select gelatin with appropriate bloom strength and
monitor base absorption capacity to ensure capsule stability throughout shelf life.
These parameters guide formulation decisions for both shell and fill materials to
minimize interactions and maximize product stability.
3.15 What should be the temperature and humidity range of the area where the soft
gelatin capsules are manufactured?

Temperature and humidity conditions are critical parameters in soft gelatin capsule
manufacturing, with different requirements for each production stage:

Gelatin Solution Preparation: • Temperature: 60-65°C (maintained in jacketed vessels) •

This elevated temperature ensures complete gelatin hydration and dissolution • Precise
temperature control prevents gelatin degradation while ensuring proper viscosity

Encapsulation/Rotary Die Process: • Temperature: 21-24°C (room temperature) •

Relative Humidity: 35-45% • Critical for proper ribbon formation and optimal die
performance • Higher humidity may cause sticking issues; lower humidity may cause
premature drying • Temperature consistency across the manufacturing area prevents
viscosity variations

Drying Operations: • Initial Drying:

• Temperature: 21-24°C

• Relative Humidity: 20-30%

• Controlled to prevent case hardening (surface drying too quickly)

• Main Drying Phase:

• Temperature: 20-22°C

• Relative Humidity: Gradually reduced from 30% to 20%

• Slow, controlled moisture removal prevents capsule deformation

• Typically requires 24-72 hours depending on capsule size

• Final Drying:

• Temperature: 21-24°C

• Relative Humidity: 20-25%

• Target final moisture content: 6-10%

Packaging Operations: • Temperature: 21-24°C • Relative Humidity: 35-45% • Prevents

moisture pickup or loss during handling and packaging

The manufacturing facility should have: • HVAC systems with precise temperature and
humidity controls • Separate zones for different manufacturing stages • Continuous
environmental monitoring systems • Dehumidification and humidity generation
capabilities • Air filtration systems to prevent contamination
Maintaining these environmental parameters is essential for consistent product quality,
physical appearance, and mechanical properties of the finished capsules. Deviations
can lead to defects like sticking, deformation, brittleness, or excessive softness.
3.16 Discuss non gelatinous capsule shells.

Non-gelatinous capsule shells have been developed as alternatives to traditional

gelatin capsules to address specific limitations and market needs:

1. HPMC (Hydroxypropyl Methylcellulose) Capsules: • Composition: Derived from

plant cellulose, may contain gelling agents (carrageenan, gellan gum) •
Advantages:

o Vegetarian/vegan-friendly

o Lower moisture content (4-6%) providing better stability for

hygroscopic/moisture-sensitive drugs

o Broader pH dissolution profile (2-9)

o Reduced cross-linking with aldehydes

o Stable across wider humidity/temperature ranges • Limitations:

o Higher oxygen permeability than gelatin

o Different mechanical properties requiring machine adjustments •

Commercial examples: Vcaps®, Quali-V®

2. Pullulan Capsules: • Composition: Natural polysaccharide produced by

fermentation of starch using Aureobasidium pullulans • Advantages:

o Excellent oxygen barrier properties

o Good transparency and glossiness

o Suitable for oxygen-sensitive materials

o Vegetarian source • Limitations:

o Higher cost than gelatin or HPMC

o Limited availability • Commercial example: NP Caps®

3. Starch Capsules: • Composition: Modified starch, typically potato or maize

derived • Advantages:

o Readily biodegradable

o Renewable resource-based

o Good stability • Limitations:

o Limited mechanical strength

o Manufacturing challenges • Commercial example: Capill®

 4. PVA (Polyvinyl Alcohol) Capsules: • Composition: Synthetic water-soluble
polymer • Advantages:

o Excellent barrier properties

o Chemical stability

o Very low moisture content • Limitations:

o Synthetic origin (not natural)

o Regulatory considerations

5. Enteric Capsule Shells: • Composition: Modified HPMC or coated capsules with

enteric polymers • Advantages:

o Targeted intestinal delivery

o Protection from gastric environment

o Replaces enteric coating process • Commercial example: DRcaps™,

Vcaps® Enteric

Manufacturing considerations for non-gelatinous capsules: • Modified production

processes compared to gelatin • Different film-forming mechanisms • Adjusted
dipping/molding temperatures • Modified drying conditions • Different sealing methods
for two-piece capsules

These alternatives continue to gain market acceptance due to religious, cultural, and
dietary preferences, as well as their technical advantages for specific formulation
challenges.
3.17 Explain quality control tests of gelatin.

Quality control tests for pharmaceutical-grade gelatin ensure its suitability for capsule
manufacturing:

1. Bloom Strength (Gel Strength): • Method: Force measurement using bloom

gelometer on standardized gel (6.67% w/w, 16-18h maturation at 10°C) •
Acceptance criteria: 150-280g for capsule-grade gelatin • Significance:
Determines mechanical strength, elasticity, and formability of capsules

2. Viscosity: • Method: Rotational viscometer measurement at standardized

concentration and temperature • Typical range: 3.5-4.5 mPa·s (for 6.67%
solution at 60°C) • Significance: Critical for processing properties during capsule
formation

3. Gel Point/Setting Point: • Method: Temperature at which gelatin solution begins

to form gel during cooling • Typical range: 28-32°C • Significance: Influences
manufacturing process parameters

4. Moisture Content: • Method: Loss on drying at 105°C or Karl Fischer titration •

Acceptance criteria: 8-15% typically • Significance: Affects storage stability and
microbial growth potential

5. pH Value: • Method: Potentiometric measurement of standardized solution •

Typical range: 4.5-6.5 (Type A), 5.5-7.5 (Type B) • Significance: Impacts
compatibility with fill materials

6. Isoelectric Point: • Method: Electrophoretic mobility measurement • Range: 4.7-

5.6 (Type A), 5.0-9.0 (Type B) • Significance: Affects drug-gelatin interactions

7. Microbiological Quality: • Methods: Total aerobic microbial count, specified

pathogens testing • Acceptance criteria: TAMC <1000 CFU/g, absence of
pathogens • Significance: Ensures safety and stability

8. Heavy Metal Content: • Method: Atomic absorption spectroscopy or ICP-MS •

Acceptance criteria: Lead <10ppm, arsenic <1ppm, mercury <0.15ppm •
Significance: Safety requirement

9. Clarity/Color: • Method: Visual or spectrophotometric comparison • Acceptance

criteria: Product-specific requirements • Significance: Aesthetic and quality
indicator

10. Ash Content: • Method: Residue on ignition test • Acceptance criteria: Typically
<2% • Significance: Indicates mineral content and purity
 11. Dissolution Test: • Method: Standardized dissolution of gelatin films •
Acceptance criteria: Complete dissolution within specified time • Significance:
Predicts capsule performance

12. Sulfur Dioxide Content: • Method: Titration or specific ion electrode •

Acceptance criteria: <50ppm typically • Significance: Residual processing agent,
potential allergen

13. Transmittance/Turbidity: • Method: Spectrophotometric measurement of light

transmission • Acceptance criteria: Product-specific requirements •
Significance: Indicator of clarity and purity

These tests ensure batch-to-batch consistency, manufacturing processability, and final

product quality. Specifications may vary depending on the specific capsule type and
application.